![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Bartsch, Detlef K.; Gercke, Norman; Strauch, Konstantin; Wieboldt, Ronja; Matthaei, Elvira; Wagner, Vinona; Rospleszcz, Susanne; Schaefer, Agnes; Franke, Frederike S.; Mintziras, Ioannis; Bauer, Christian; Grote, Tobias; Figiel, Jens; Di Fazio, Pietro; Burchert, Andreas; Reinartz, Silke; Pogge von Strandmann, Elke; Kloeppel, Guenter und Slater, Emily P.
(2018):
The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer.
In: Journal of Clinical Medicine, Bd. 7, Nr. 10, 295
[PDF, 476kB]
Muckenhuber, Alexander; Berger, Anne Katrin; Schlitter, Anna Melissa; Steiger, Katja; Konukiewitz, Björn; Trumpp, Andreas; Eils, Roland; Werner, Jens; Friess, Helmut; Esposito, Irene; Kloeppel, Guenter; Ceyhan, Gueralp O.; Jesinghaus, Moritz; Denkert, Carsten; Bahra, Marcus; Stenzinger, Albrecht; Sprick, Martin R.; Jaeger, Dirk; Springfeld, Christoph und Weichert, Wilko
(2018):
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
In: Clinical Cancer Research, Bd. 24, Nr. 2: S. 351-359
Mihaljevic, Andre; Buechler, Peter; Harder, Jan; Hofheinz, Ralf; Gregor, Michael; Kanzler, Stephan; Schmiegel, Wolff; Heinemann, Volker; Endlicher, Esther; Kloeppel, Guenter; Seufferlein, Thomas und Geissler, Michael
(2009):
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.
In: BMC Surgery
9:1
[PDF, 284kB]
Eriksson, Barbro; Kloeppel, Guenter; Krenning, Eric; Ahlman, Hakan; Ploeckinger, Ursula; Wiedenmann, Bertram; Arnold, Rudolf; Auernhammer, Christoph J.; Koerner, Meike; Rindi, Guido und Wildi, Stefan
(2008):
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - Well-differentiated jejunal-ileal tumor/carcinoma.
In: Neuroendocrinology, Nr. 1: S. 8-19
[PDF, 282kB]